Honeywell > Case Studies > Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Honeywell Logo
Customer Company Size
Large Corporate
Product
  • Honeywell Two-Way Cellular-Connected Handheld Blood Glucose Meter
Tech Stack
  • Machine-to-Machine (M2M) Communication
  • Cellular Connectivity
Implementation Scale
  • Enterprise-wide Deployment
Impact Metrics
  • Revenue Growth
  • Customer Satisfaction
  • Digital Expertise
Technology Category
  • Networks & Connectivity - Cellular
  • Analytics & Modeling - Machine Learning
Applicable Industries
  • Healthcare & Hospitals
Use Cases
  • Remote Patient Monitoring
  • Machine Condition Monitoring
Services
  • System Integration
About The Customer
The customer is a global healthcare device manufacturer specializing in helping people manage chronic conditions, particularly diabetes. They produce devices that transmit glucose levels and other pertinent information in real time to a network of providers. The company has a significant presence in the healthcare market and aims to expand its product offerings and services. With a focus on innovation and customer satisfaction, the company is dedicated to improving the quality of life for individuals with chronic conditions through advanced medical devices.
The Challenge
The global healthcare device manufacturer faced the challenge of quickly filling thousands of pre-release orders for a newly approved glucose monitoring device. Additionally, they needed to prepare for the successful deployment of future healthcare devices by establishing a partnership with an experienced managed mobility services provider. The company was experiencing overwhelming success and needed to ensure that they could meet the high customer demand for their new diabetes monitoring device.
The Solution
To address the overwhelming success and high demand for their new diabetes monitoring device, the company engaged Honeywell to deploy a two-way, cellular-connected handheld blood glucose meter. This device falls into the growing category of machine-to-machine (M2M) products, which are networked devices that communicate without human intervention, often as part of remote monitoring. Honeywell, with its extensive experience in M2M, leveraged its wide-ranging product expertise to deploy 100,000 devices. This partnership allowed the healthcare device manufacturer to quickly and efficiently meet the pre-release and new orders for their glucose monitoring device.
Operational Impact
  • The company has established an almost immediate and significant foothold in the $250 billion diabetes-management market.
  • With the successful launch of its product, the company gains funds for anticipated new products and expansion of services.
  • It has established a relationship with a reliable managed mobility services provider that will help the company rapidly deploy new devices in the future.
Quantitative Benefit
  • Deployed 100,000 devices in 18 months.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

Related Case Studies.

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.